<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR20">
 <label>20.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Dahbour</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Jamali</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Alhattab</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Al-Radaideh</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Ababneh</surname>
    <given-names>O</given-names>
   </name>
   <name>
    <surname>Al-Ryalat</surname>
    <given-names>N</given-names>
   </name>
   <name>
    <surname>Al-Bdour</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Hourani</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>Msallam</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Rasheed</surname>
    <given-names>M</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Mesenchymal stem cells and conditioned media in the treatment of multiple sclerosis patients: clinical, ophthalmological and radiological assessments of safety and efficacy</article-title>
  <source>CNS Neurosci Ther</source>
  <year>2017</year>
  <volume>23</volume>
  <fpage>866</fpage>
  <lpage>874</lpage>
  <pub-id pub-id-type="doi">10.1111/cns.12759</pub-id>
  <?supplied-pmid 28961381?>
  <pub-id pub-id-type="pmid">28961381</pub-id>
 </element-citation>
</ref>
